Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Grade I or II Essential Hypertension”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)Study completedNCT02072330
What this trial is testing

Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.

Who this might be right for
Grade I or II Essential Hypertension
Takeda 353
Testing effectiveness (Phase 2)Study completedNCT02322450
What this trial is testing

Phase IIa Study of the Product QGC001 Compared With Placebo in Patients With Essential Hypertension

Who this might be right for
Essential Hypertension
Quantum Genomics SA 34
Large-scale testing (Phase 3)UnknownNCT02407210
What this trial is testing

Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential Hypertension

Who this might be right for
Essential Hypertension
Jiangsu HengRui Medicine Co., Ltd. 304

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation